A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
National Cancer Institute (NCI)
University of Regensburg
Memorial Sloan Kettering Cancer Center
New Approaches to Neuroblastoma Therapy Consortium
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)
Duke University
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Children's Hospital Los Angeles